« Back to Inflammatory Disorders

Autoimmune Connective Tissue Diseases

»Discuss the skin changes of lupus erythematosus.
»What is acute cutaneous lupus erythematosus (ACLE)?
»Are there any common skin eruptions that may be confused with acute cutaneous lupus erythematosus?
»What is subacute cutaneous lupus erythematosus (SCLE)?
»Do patients with SCLE have SLE?
»How do you make a diagnosis of SCLE?
»What is the initial workup of SCLE?
»How is SCLE managed?
»What is chronic cutaneous lupus erythematosus?
»Describe the skin changes of discoid lupus erythematosus.
»Do patients with DLE develop systemic lupus erythematosus?
»How is discoid lupus erythematosus treated?
»What is minocycline-induced lupus?
»What is lupus panniculitis?
»Describe the bullous eruption of SLE.
»How is the bullous eruption of systemic lupus erythematosus treated?
»What is neonatal lupus erythematosus (NLE)?
»Which tests should be done in an infant with suspected NLE?
»Once a diagnosis of NLE is made, what workup should be done?
»What is the lupus band test?
»What is scleroderma?
»What is the CREST syndrome?
»Describe the early cutaneousfindings in progressive systemic sclerosis (PSS).
»What is dermatomyositis?
»Are there skin changes diagnostic of dermatomyositis?
»How do you diagnose dermatomyositis?
»Are any diseases associated with dermatomyositis?
»What is the antisynthetase syndrome?
»What is an overlap syndrome?
»What is mixed connective tissue disease?
»What is the antiphospholipid antibody syndrome?
»What are some other connective tissue diseases with cutaneous manifestations?
»What autoantibodies are associated with the different autoimmune connective tissue diseases?

 
 
 

How do you make a diagnosis of SCLE?

SCLE is a clinical diagnosis based on the presence of a typical photodistributed eruption and a skin biopsy consistent with cutaneous LE. Direct immunofluorescence testing may also be helpful. In addition to granular deposition of immunoreactants at the dermal–epidermal junction, particulate deposition of IgG within the epidermis has been described in SCLE. Most patients with SCLE have circulating antibodies to Ro/SS-A (Sjögren’s syndrome A) and, less commonly, to La/SS-B (Sjögren’s syndrome B). These antibodies are not demonstrable in all patients with SCLE; thus, their absence does not exclude this diagnosis. Additionally, a negative ANA does not exclude the diagnosis of SCLE, and some patients may have positive titers to Ro/SS-A or La/SS-B but test negative for ANA.